Genomma Lab International SAB DE CVGenomma Lab International SAB DE CVGenomma Lab International SAB DE CV

Genomma Lab International SAB DE CV

No trades
See on Supercharts

Price target

1.300.000.00%
The 3 analysts offering 1 year price forecasts for GNMLF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to GNMLF in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GNMLF EPS for the last quarter is 0.03 USD despite the estimation of 0.03 USD. In the next quarter EPS is expected to reach 0.02 USD. Track more of Genomma Lab International SAB DE CV financials and stay on top of what is up with the company.
In the next quarter Genomma Lab International SAB DE CV revenue is expected to reach ‪189.38 M‬ USD. Check out Genomma Lab International SAB DE CV revenue and earnings and make informed decisions.
According to analysts, GNMLF price target is 1.30 USD with a max estimate of 1.59 USD and a min estimate of 0.87 USD. Check if this forecast comes true in a year, meanwhile watch Genomma Lab International SAB DE CV stock price chart and keep track of the current situation with GNMLF news and stock market news.